Bob Stern work email
- Valid
- Valid
Bob Stern personal email
- Valid
Bob Stern phone numbers
Bob has served as as a board member most recently as Chairman of Cardiac-Tec, and Vice Chairman of, LuSeed Vascular and Mivi Neuroscience. During his career he led talented teams as President and CEO of multiple companies, currently Sanibel Capital an investment firm and recently Vascular Dynamics Inc focused on the management of refractory high blood pressure from November of 2011 to November 2017. In that role Bob raised $33 million dollars of venture funding. The funds have been utilized to develop the product, gain approval for a PMA study in the United states and a CE (Conformité Européenne) Mark in Europe and complete their FIM Trial. Bob served as Micrus Endovascular’s(MEND, NASDAQ), President and Chief Operating Officer from November 2007 through December 2011. Prior to that, he was the Micrus Executive Vice President and Chief Financial Officer from January 2004 to November 2007. Bob was appointed Micrus Secretary in March 2005. From September 2000 to January 2004, Mr. Stern served as the President and Chief Executive Officer of Context Connect, Inc., a telecommunications company raising $5 million. From March 2000 to September 2000, he served as the Executive Vice President of Qixel Capital Group, an investment holding company operating 15 companies in Asia. From January 1996 to March 2000, he served as the Vice President and Chief Financial Officer of InnerDyne, Inc., a medical device company (IDYN, NASDAQ). Mr. Stern received his B.S. in Business Administration from the University of New Hampshire, Whittemore School of Business and Economics, and his MBA from the University of New Mexico, Anderson School of Management.Mr. Stern currently serves on multiple philanthropic and commercial boards. • Thirty Years of senior management experience.• Both start up and turnaround experience • Successful fund raising track record• Board of Directors experience in multiple fields• Successful public offering execution track record• Sarbanes Oxley and International compliance experience • SEC and related public filing expertise• Experienced in the management and negotiation of international licensing agreements, distribution agreements and corporate alliances
-
EmeritusTahoe Prosperity CenterSanibel, Fl, Us -
ChairmanCardiac-Tech Ltd Apr 2023 - PresentFollowing open heart surgery, patients often experience rhythm disturbances which can lead to serious complications during recovery. To counter this, cardiac surgical patients are typically fitted with a temporary pacing system in order to regulate the heart’s rhythm and ensure a near-normal cardiac output is maintained.Post-surgical temporary pacing therapy is achieved by attaching a pacing wire to the outer surface of the heart, feeding the wire through the patient’s abdomen, and attaching this to an extension lead which is inserted into a temporary pacing device that is kept at the bedside.Research and experience show epicardial pacing wires to be both unstable and subject to degeneration from epithelialisation (scar tissue formation), with published articles highlighting the potential dangers of temporary pacing and recommending that checks on the pacing parameters of such devices be performed at least every 12 hours.This instability, coupled with devices that lack the sophistication seen in modern permanent pacing, as well as device management typically undertaken by ITU doctors and nurses operating in high pressured environments, can lead to a failure to identify acute and sudden changes in device function or patient underlying rhythm. As a result, cardiac output may be affected, resulting in higher use of inotrope (muscle contraction) medication and an extended and costly ITU stay. Other more serious consequences of a failure to recognize acute changes in pacing function can lead to serious harm to the patient, including causing cardiac arrest and death. -
Vice Chairman Of The BoardLuseed Vascular Dec 2022 - PresentThis first-in-category Intrasaccular Device to be used as acute and long-term solution, For both bifurcation and sidewall aneurysms -
Vice Chairman Of The BoardMivi Neuroscience, Inc Mar 2020 - PresentEden Prairie, Mn, UsMIVI is on a mission to deliver groundbreaking solutions for improving outcomes in challenging neurointerventional procedures. We go beyond current options to solve two major unmet needs identified by neurointerventionalists—improving aspiration outcomes for strokes, and reducing distal embolization. -
EmeritusTahoe Prosperity Center Nov 2011 - Present
-
Chairman And Vice Chair Of The BoardTahoe Prosperity Center Jan 2019 - Dec 2020
-
Vice ChairmanTahoe Prosperity Center Jan 2019 - Jan 2020
-
Medtech Industry Advisor Serving On Boards To Help Make A DifferenceSanibel Capital Nov 2017 - Present
-
Board MemberVascular Dynamics Nov 2011 - Oct 2017Irvine, Ca, UsPresident and Chief Executive OfficerMember of the Board Of Directors -
President & Chief Executive OfficeerVascular Dynamics Oct 2011 - Oct 2017Irvine, Ca, Us
-
Member Board Of DirectorsNeuravi Aquired By Jnj 2017 Mar 2015 - May 2017Fully focused on improving acute stroke treatment, Neuravi develops and globally markets innovative medical devices for neurointerventional therapy that are based upon extensive research into the clot and occlusions that cause stroke. Through its investment in the Neuravi Thromboembolic Initiative (NTI), Neuravi supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics, in order to improve patient outcomes in stroke.
-
Past Board MemberReverse Medical Aquired By Covidien/Medtronic Jan 2011 - Jan 2014Company sold to Covidien/MDT
-
Past Board MemberFlexible Stenting Solutions, Inc. Jan 2011 - Mar 2013Flexible Stenting was acquired by JNJ March 2013
-
Board MemberTravel Wrangler Jan 2011 - Feb 2012
-
Past Board MemberNexeon Medsystems, Inc Jan 2010 - Oct 2011
-
President & Chief Operating OfficerMicrus Endovascular Sold To Jnj 2010 Jan 2004 - Oct 2010Micrus Endovascular Corporation (NASDAQ: MEND) develops and markets products that are used in the minimally invasive treatment of cerebral aneurysms and ischemic stroke. Proprietary Micrus microcoils and access platforms provide a safe and reliable alternative to a highly invasive and costly neurosurgical procedure (craniotomy and aneurysmal clipping) that requires extended operating room and recovery times. Micrus’ microcoils, combined with its access products such as guidewires, balloon catheters, guide cathers and microcatheters, allow physicians to treat cerebral aneurysms less invasively through the arterial system. Micrus markets its products through a direct sales force in North America and parts of Europe, and through distributors in Japan, Europe, Latin America, Asia and the Middle East.
-
President CeoContext Connect Inc. Jul 2000 - Jan 2004Context Connect, LLC. (“CCL”) is a privately-held company dedicated to revolutionizing the way individuals ‘find and connect’ to one another, privately. Context Connect provides a proprietary technology that 1) allows for simple directory-based connectivity and other transactions between individuals, 2) retains the privacy of individual’s information and 3) generates communication-based transactions for service providers such as social networking sites and carriers.Context Connect is headquartered in Boston, Massachusetts with offices in Wellington, New Zealand. Investors in Context Connect include Equity Resource Investments, Bingham McCutchen (via the Gould Fund), Sitel Corporation and Bay Resource Corporation.The company has developed a robust portfolio of intellectual property throughout the world focused on the area of private, directory-based connectivity.The company offers a simple directory platform that allows individuals to ‘find and connect’ one another without revealing the actual contact information of the target subscriber. Through the company’s Directory as a Service (Daas) Platform, the ‘click to talk’ widgets allow people to get connected based on contextual names or aliases that they control and manage, rather than phone numbers or contact information that are 1) private to individuals and 2) hard to remember
-
Executive Vice PresidentQixel Capital Group, Inc. Jan 2000 - Jul 2000Qixel Capital Group, Inc. is an Internet holding company that cultivates companies focused on the development of business-to-business eCommerce in Asia/Pacific. Qixel's specialized services enhance Internet infrastructure in Southern Hemisphere and Pacific-rim countries by partnering with local companies to build efficiencies, speed learning curves and deploy proven Internet solutions in new markets. Through its existing network of eCommerce-focused companies, Qixel provides a variety of resources to enable end-to-end eCommerce solutions for nascent market entrants.
-
Vice President, Chief Financial OfficerInnerdyne, Inc. Nasdaq (Idyn) Jan 1996 - Jan 2000Led, legal, accounting, and finance team through public offering as InnerDyne, Inc.Developed infrastructure, which led to profitability in 28 months after $52 million in sequential lossesDeveloped IT and WAN systems for manufacturing and financial management Responsible for strategic planning and negotiation of corporate alliances (AHP,SDG. )Responsible for all finance related issues including, banking, corporate finance, P&L, treasury, risk management, forecastingResponsible for IR program and buy and sell side analytical coverage.Responsible as the senior financial officer for all public filings, press releases and investor reportingDeveloped and filed a series of radioisotope and drug delivery patents, focused on restenosis, and oncology these technologies are currently in animal trials
-
Vice President Corporate Finance, Chief Financial OfficerRhomed Inc. Jan 1991 - Jan 1996Responsible for Worldwide technology and product licensing.Established a European business and research division.Manage all domestic and international business affairs.Negotiated all marketing, manufacturing and distribution agreements. Successfully negotiated agreements with 5 multi-national companies to commercialize three radiopharmaceutical products.
Bob Stern Skills
Bob Stern Education Details
-
Unh Peter T. Paul College Of Business And EconomicsFinance -
Unm Anderson School Of ManagementBusiness
Frequently Asked Questions about Bob Stern
What company does Bob Stern work for?
Bob Stern works for Tahoe Prosperity Center
What is Bob Stern's role at the current company?
Bob Stern's current role is Emeritus.
What is Bob Stern's email address?
Bob Stern's email address is bo****@****ern.com
What is Bob Stern's direct phone number?
Bob Stern's direct phone number is +165096*****
What schools did Bob Stern attend?
Bob Stern attended Unh Peter T. Paul College Of Business And Economics, Unm Anderson School Of Management.
What are some of Bob Stern's interests?
Bob Stern has interest in Economic Empowerment.
What skills is Bob Stern known for?
Bob Stern has skills like Compliance, Start Ups, Sox, Executive Management, Mergers, Medical Devices, Product Development, Strategic Planning, Fundraising, Team Building, Venture Capital, Customer Relations.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial